Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Oral PTH (1-34) in Healthy Men
NCT02571140Phase 1Completed
- Sponsor
- Entera Bio Ltd.
- Start
- Oct 2013
- Primary completion
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, open-label trial of teriparatide in osteoporosis and hypoparathyroidism (2 arms), sponsored by Entera Bio Ltd. Primary endpoint: Peak Plasma Concentration. Started Oct 2013; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosishypoparathyroidism
Beyond the preview
Go deeper on NCT02571140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571140.